FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Labetalol Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 03/01/2017
»Therapeutic Categories: Cardiovascular

Expand all

Akorn Pharmaceuticals (New 03/02/2017)

Company Contact Information:
800-932-5676

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5mg/mL (100mg/20mL) Multi-Dose vial (NDC 17478-420-20) Due to release mid-May 2017 Next production scheduled in April 2017 Other
5mg/mL (200mg/40mL) Multi-Dose vial (NDC 17478-420-40 ) Due to release late March 2017 Next production scheduled in April 2017 Other

Hospira, Inc. (Revised 06/23/2017)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg/mL (100 mg/20 mL) Multiple Dose Glass Fliptop Vial (NDC 0409-2267-20) Next delivery: Late June 2017; Estimated recovery: Mid August 2017 Shortage per manufacturer: Manufacturing Delay

Dear Customer Letter

Other
5 mg/mL (200 mg/40 mL) Multiple Dose Glass Fliptop Vial l (NDC 0409-2267-54) Next delivery: Late June 2017; Estimated recovery: Mid August 2017 Shortage per manufacturer: Manufacturing Delay

Dear Customer Letter

Other
5 mg/mL (20 mg/4 mL) Carpuject™ Luer Lock Glass Syringe (no needle) (NDC 0409-2339-34) Next delivery: Late June 2017; Estimated recovery: September 2017 Shortage per manufacturer: Manufacturing Delay

Dear Customer Letter

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English